Inherited Metabolic Disease
Clinical research includes glycogen storage disease type Ib, with attention to neutropenia and treatment options aimed at improving hematologic and metabolic complications in children.
- Glycogen storage disease type Ib
- Neutropenia
- Pediatric metabolic disorders
The sponsor’s work in this area reflects interest in rare inherited conditions requiring targeted supportive and disease-specific care.
Epilepsy and mTOR-Related Disorders
Several studies focus on drug-resistant epilepsy linked to tuberous sclerosis complex and other mTOR pathway-associated conditions, including mTORopathies and focal cortical dysplasia.
- Tuberous sclerosis complex
- Drug-resistant epilepsy
- mTOR pathway disorders
Research also covers seizure prevention in infants and the management of epilepsy across rare neurodevelopmental syndromes.
Pediatric Neuro-Oncology
The sponsor is active in pediatric brain tumors, including medulloblastoma, diffuse intrinsic pontine glioma, and high-grade glioma, with interest in tumors associated with tuberous sclerosis complex.
- Medulloblastoma
- Diffuse intrinsic pontine glioma
- High-grade glioma
These studies address difficult-to-treat central nervous system malignancies in children and associated molecularly defined disease subgroups.
Pediatric Gastroenterology and Immune-Mediated Disease
Clinical activity also includes ulcerative colitis in children and adolescents, with interest in immune-mediated intestinal inflammation and biologic treatment options.
- Ulcerative colitis
- Pediatric inflammatory bowel disease
- Biologic therapy
This area extends the sponsor’s research profile beyond rare genetic and neurologic disease into chronic pediatric inflammatory conditions.
